Alzheimer’s Research UK Advanced Clinical Fellowship 2026: Up to £750,000 for UK Dementia Clinician-Researchers

Alzheimer’s Research UK Advanced Clinical Fellowship 2026: Up to £750,000 for UK Dementia Clinician-Researchers

The Alzheimer’s Research UK Advanced Clinical Fellowship is a substantial career-development award for a clinician who wants to build an independent research programme without abandoning clinical practice. The 2026 round is open for applications and has a stated deadline of 15 October 2026. Alzheimer’s Research UK says the scheme can provide up to £750,000, covering the applicant’s salary for up to 50% dedicated research time alongside justified costs needed to carry out the proposed work.

This is not a general postgraduate scholarship, a small project grant, or a promise of unrestricted money. It is a competitive fellowship for clinically qualified professionals active in the United Kingdom, supported by a UK host institution and an established investigator who can sponsor the work. The research must fit Alzheimer’s Research UK’s remit, which focuses on the treatment, diagnosis and prevention of dementia. The funder is particularly interested in applications involving interventional clinical trials and samples, while also welcoming applicants who want to gain clinical-trial experience as part of their fellowship.

The award is designed around a practical problem in medical research: clinicians often need protected time, training and a supportive research environment to move from promising early work toward independence. The scheme therefore asks for more than an interesting scientific question. A strong application needs a credible clinical setting, a clear development plan, a realistic balance between patient-facing duties and research, and an explanation of how the work could improve understanding or care in dementia.

Key details

The amount in the table is a programme maximum, not an automatic award. Alzheimer’s Research UK says the grant covers salary for the research portion of the fellowship and justified project costs. Applicants should build a defensible costed plan rather than treating £750,000 as a guaranteed personal stipend.

What the fellowship supports

The core commitment is protected research time. The funder expects the fellowship to support up to 0.5 full-time equivalent for research, with the remainder available for clinical work when that split is appropriate and clearly justified. The page says the research-to-clinical balance can be negotiated so that the fellowship is beneficial, but that flexibility still needs to be explained. A proposal should show how the protected time will be used, what the clinical role contributes, and why the two activities strengthen rather than undermine each other.

The award can also support justified project costs. Alzheimer’s Research UK’s cost guidance lists consumables, materials, laboratory costs, small project-specific equipment, additional staff time, travel and subsistence for meetings and conferences, relevant training, open-access publication costs, and Patient and Public Involvement and Engagement. A period of overseas training can be included where it is relevant and properly justified. These categories are useful for planning, but they do not make every possible expense eligible. Each cost should have a direct connection to the research programme and should not already be funded elsewhere.

The scheme is especially relevant to clinical and translational projects. The current call notes a particular interest in interventional clinical trials and samples. That does not mean every applicant must propose a trial. It does mean that a project addressing a real diagnostic, treatment or prevention problem should explain how clinical evidence, patient samples, clinical pathways or translational partnerships will move the work beyond a purely descriptive exercise.

The fellowship can also be a route for a clinician who needs structured experience in clinical-trial methods. Alzheimer’s Research UK explicitly welcomes applicants who want to gain experience within a clinical trial alongside their research. Applicants should connect that training need to a defined career plan rather than presenting training as an end in itself.

Who is likely to fit

The obvious fit is a clinically qualified professional already active in the UK, with enough research experience to demonstrate momentum but still developing toward independence. The funder names neurologists, clinical psychologists, nurses and allied health professionals as examples of eligible clinical backgrounds. The list is not a substitute for the full eligibility rules, but it makes clear that the scheme is not restricted to one medical specialty.

The applicant should be able to show a record of original and impactful research that is becoming stronger over time. That record may include publications, presentations, reviewing, collaborations, clinical research responsibilities or other evidence of contribution. The relevant question is not whether the applicant has the longest publication list. It is whether the proposed fellowship is a logical next step and whether the applicant has the skills, support and development plan needed to make good use of it.

The work must align with Alzheimer’s Research UK’s research strategy, especially dementia treatment, diagnosis or prevention. The call is therefore a poor fit for a project that mentions dementia only incidentally, or for research whose main purpose sits outside the charity’s remit. A strong fit can be clinical, laboratory-based, translational, methodological or interdisciplinary, provided the link to dementia outcomes is specific.

The applicant must have a UK-based host institution and an established investigator at that institution who will act as sponsor and provide the facilities needed for the programme. Collaborators outside the UK may be included, but an overseas collaborator does not replace the UK host requirement. The host institution must also provide a letter of support, and collaboration letters may be needed where the project depends on external partners.

Eligibility and host arrangements

Start by separating three questions: whether you are personally eligible, whether the science fits, and whether the host environment can deliver the work. Passing one test does not automatically pass the others.

For personal eligibility, confirm that you are clinically qualified and active in the UK, and that your research experience supports an application for advanced clinical development. The current page expects a strong track record with increasing experience in publication, presentation and review, as well as progress toward independence and a commitment to collaboration and partnership.

For project eligibility, map the central research question to treatment, diagnosis or prevention of dementia. If your work involves a clinical trial, patient samples or a clinical intervention, state exactly what the fellowship will add. If it is a laboratory or data project, identify the path from the planned work to a meaningful dementia-research outcome. Avoid assuming that a broad neuroscience label is enough.

For the host, ask the proposed sponsor to review the full project before you write the final application. The sponsor should be able to confirm access to facilities, patients, samples, data, trial infrastructure, specialist methods or other resources that the plan depends on. The institutional letter should do more than say that the organisation supports the applicant; it should make the research environment and supervision credible.

The funder allows joint funding between Alzheimer’s Research UK and the host institution, provided it is explained clearly in the application, costings and institutional letter. If your institution will contribute salary, facilities or other costs, agree the arrangement early and make sure the application does not request the same cost from two sources.

Application process

Applications are made through Alzheimer’s Research UK’s grant application website. The programme page says that grant schemes appear on that system when the round is open and new applications are being accepted. Create an account early, read the form in full, and check whether the system requires institutional approvals or named contributors before submission.

The application should connect the scientific case, clinical context, career development and costings. Do not treat these as separate essays. The research plan should explain why the question matters; the clinical context should explain why this applicant and setting are well placed to answer it; the development plan should show what capabilities will be gained; and the budget should make the proposed work possible without padding.

The current review process provides several clues about what matters. Applications are assessed in open competition on scientific merit in relation to Alzheimer’s Research UK’s remit. The strength of the applicant and the dementia-research environment are also considered. After expert triage, shortlisted applicants can respond to feedback and take part in an interview. Prospective Fellows are asked to give a five-minute PowerPoint presentation about their work during the interview process.

The application also includes a Plain English proposal and Patient and Public Involvement plans. Those materials are not decorative summaries. They let people outside the specialist field understand the problem, the proposed work and the possible value to people affected by dementia. Write them for clarity and accuracy, without promising a clinical benefit that the research cannot yet establish.

Materials to prepare

The exact form fields and upload requirements should be checked in the live application system, but the official programme page identifies the main components you should prepare:

• A focused research proposal aligned with dementia treatment, diagnosis or prevention.
• A credible career-development plan explaining how the fellowship moves you toward independence.
• A realistic clinical and research time split, including the reason for up to 0.5 FTE protected research time.
• A detailed costing for salary and directly justified project expenses.
• A Plain English proposal suitable for lived-experience review.
• A Patient and Public Involvement and Engagement plan.
• A letter of support from the UK host institution.
• A sponsor or supervisor arrangement with an established investigator at the host institution.
• Letters of support from collaborating organisations where the project depends on them.
• A short presentation that can be adapted for the five-minute interview if shortlisted.

For each document, use the same project name, endpoints and time period. Inconsistencies between the scientific proposal, budget and institutional letter create avoidable doubts. If the proposal includes an overseas training period, explain the skill gap it addresses, why that training is necessary, and how the capability will be brought back into the UK host environment.

Timeline and deadline

The 2026 call opened in July. The application deadline is 15 October 2026. Alzheimer’s Research UK expects funding outcomes between December 2026 and January 2027. The organisation says the fellowship is expected to be completed within five years, although the duration can be negotiated where that creates a better balance between clinical and research commitments.

Work backward from the deadline. A host institution may need time to review the science, approve the costs and sign its letter. Collaborators may need to confirm access to samples, data, patients, trial sites or training. A sponsor may need to read multiple drafts. If you wait until October to address those dependencies, the application can become a rushed description of an idea rather than a credible research programme.

The review stages also affect planning after submission. Expert triage comes first. Shortlisted applicants may then have an opportunity to respond to concerns, take part in an interview and present their work. Keep a concise explanation of the project ready so that you can answer questions about feasibility, clinical relevance, sample size or access, depending on the nature of the proposal.

How to make the case stronger

Begin with the clinical problem, not with a list of methods. Explain who is affected, what is currently difficult and what evidence is missing. Then state the smallest set of research aims that can answer the central question within the proposed time and resources.

Make the protected-time calculation visible. If research will occupy half of the appointment, explain what will happen during the clinical portion and how the two roles interact. A plan that quietly assumes full-time research while requesting 0.5 FTE will look unrealistic. Conversely, a plan with no clear clinical connection may miss the point of an advanced clinical fellowship.

Treat the environment as evidence. Name the facilities, specialist expertise, recruitment pathways, sample access, data governance support or trial infrastructure that the host can provide. Where something is not yet secured, say what confirmation is needed and who is responsible for obtaining it.

Use the review criteria as a writing test. Ask whether a reviewer can see scientific merit, fit with the charity’s remit, a convincing applicant-development path, a workable host environment and a plausible route to impact. Then ask whether a person living with dementia or supporting someone with dementia can understand the proposal’s purpose and limitations from the Plain English section.

Common mistakes to avoid

The first mistake is treating the maximum award as a personal cash prize. The £750,000 figure is a programme ceiling; the actual grant depends on justified salary and project costs. Build the request from the work plan.

The second is submitting a project with a weak connection to dementia treatment, diagnosis or prevention. A technically strong study can still be ineligible if it does not fit the funding remit.

The third is leaving the host arrangement until the end. A sponsor, institutional letter and access to facilities are central to this scheme, not administrative details to add after the science is finished.

The fourth is presenting a clinical-research balance that cannot work in practice. Show who covers clinical duties, when research time occurs and how supervision will protect that time.

The fifth is writing the Plain English proposal as a shortened technical abstract. It should explain the human problem, the proposed work, the uncertainty and the possible value without hiding limitations behind specialist terminology.

Finally, do not duplicate costs already funded by another source. The funder’s cost guidance allows justified research expenses, but applicants should identify other confirmed or proposed support and explain any joint funding clearly.

Frequently asked questions

Is the fellowship only for doctors?

No. Alzheimer’s Research UK gives neurologists, clinical psychologists, nurses and allied health professionals as examples of eligible clinical backgrounds. The essential test is that the applicant is clinically qualified and active in the UK and meets the research and host requirements.

Does the project have to be a clinical trial?

No. The funder is particularly interested in interventional clinical trials and samples, but the call supports projects aligned with dementia treatment, diagnosis or prevention more broadly. Explain the project’s relevance and clinical or translational pathway.

Can the host institution be outside the UK?

The host institution must be UK-based. The application may include collaborators outside the UK, and overseas training can be supported where justified, but an overseas collaborator is not a substitute for the required UK host.

How much money will an awardee personally receive?

The official page does not describe the award as a single personal stipend. It says the grant can cover salary for up to 50% FTE research time and justified project costs, with awards of up to £750,000. Your own salary arrangement and eligible costs must be confirmed through the application and institutional costings.

What happens after submission?

Applications are assessed by expert reviewers and triaged. Shortlisted prospective Fellows may respond to feedback, attend an interview and give a five-minute presentation. The funder says outcomes are expected between December 2026 and January 2027.

Where should I verify the current rules?

Use the official Advanced Clinical Fellowship page and the linked live grant application system. For eligibility or project-suitability questions, Alzheimer’s Research UK lists [email protected] and 0300 111 5555 as contact details.

Official links and next steps

The controlling source is the Alzheimer’s Research UK Advanced Clinical Fellowship page. It contains the current deadline, amount, eligibility rules, cost guidance, review process and the application link. Before submitting, read the funder’s research policies, confirm the host and sponsor arrangements, secure institutional support, and reconcile every line of the budget with the proposed research time and activities.

This opportunity is strongest for a clinician who already has a research foundation and a specific dementia question that can be developed in a supportive UK environment. If that describes you, the next practical step is to ask a potential sponsor to review a one-page outline covering the clinical problem, aims, research time, host resources, development needs and approximate costs. Use the response to decide whether the full application can be made credible before the 15 October deadline.